《公司業績》中國財險(02328.HK)全年純利245.85億元人民幣跌15.7% 末期息增至48.9分人民幣
中國財險(02328.HK)公佈截至去年12月底止全年業績,原保險保費收入5,158.07億元人民幣(下同),按年升6.3%。純利245.85億元,按年跌15.7%;每股盈利1.105元。派末期息48.9分,上年同期派47.8分。
2023年,實現保險服務收入4,572.03億元,按年增加7.7%;實現承保利潤101.89億元,減少29.1%。綜合賠付率70.6%,上升1.2個百分點;綜合費用率27.2%,持平;綜合成本率97.8%,上升1.2個百分點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.